IBNSINA PHARMA EGX:ISPH:
Q2 CONSOL NET PROFIT ATTRIBUTABLE EGP 206.9 MILLION
Q2 CONSOL NET SALES EGP 18 BILLION
Ibnsina Pharma Q2 Consol Profit EGP 206.9 Million
Story so far
Earlier from Ibnsina Pharma
- Ibnsina Pharma Board Approves Appraiser Reports Of Shorouk Specialized Hospital
- Ibnsina Pharma Q1 Consol Net Profit EGP 181.9 Million
Later from Ibnsina Pharma
- SNG: Ibnsina Pharma leads Egypt’s pharmaceutical distribution market with 31.1% share in H1 2025
- Ibnsina Pharma FY Dividend Per Share EGP 0.16
- SNG: Egypt: Ibnsina Pharma to disburse $0.0033/share cash dividend in October
- SNG: Ibnsina Pharma leads non-pharma product distribution in Egyptian pharmacies in 9 months
- Ibnsina Pharma Q3 Consol Profit EGP 271 Million
Follow Ibnsina Pharma into a list and get an email when it puts out news.
Follow Ibnsina Pharma